Praxis Precision Medicines (PRAX) Shares Outstanding (2019 - 2026)

Praxis Precision Medicines has reported Shares Outstanding (Entity) for 8 years, with the latest figure at $27.9 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 32.68% year-over-year to $27.9 million in Q2 2026; TTM through Jun 2026 was $27.9 million, a 32.68% increase from a year earlier, with the FY2025 full-year figure at $25.2 million, up 29.72% from the prior year.
• Shares Outstanding (Entity) was $27.9 million for Q2 2026 at Praxis Precision Medicines, roughly flat from $27.9 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $27.9 million in Q2 2026, with the low at $3.0 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $13.8 million, with a median of $15.5 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) climbed 1.97% in 2022, then soared 281.87% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $3.3 million in 2022, then surged by 100.29% to $6.6 million in 2023, then surged by 194.53% to $19.4 million in 2024, then climbed by 29.72% to $25.2 million in 2025, then climbed by 10.8% to $27.9 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $27.9 million (Q2 2026), $27.9 million (Q1 2026), and $25.2 million (Q4 2025), per Business Quant data.